title: Dietary tryptophan restriction in rats triggers astrocyte cytoskeletal hypertrophy in hippocampus and amygdala.
abstract: We have previously reported that dietary tryptophan (TRP) restriction in a rat crucial postnatal developmental stage induces depression-like behavior and alters dendritic spine density in CA1 pyramidal neurons and granule cells of the hippocampus. Due to astrocyte involvement in critical brain mechanisms, it seems worth to investigate possible adaptive changes in the glial population with TRP restriction. Experimental rats were fed with low TRP diet (20% of TRP level of the laboratory rat chow) from postnatal days 30-60. Antibody against glial fibrillary acidic protein (GFAP), a principal intermediate filament in astrocytes, was used to evaluate cytoskeletal hypertrophy and glial proliferation. Our results showed an increase in size and branching of GFAP-immunoreactive (IR) cells in the dorsal hippocampus and amygdala, characteristics of an astrocytic activation. No significant differences were found regarding the number of GFAP-IR cells in both regions. These results indicate that dietary TRP restriction can induce astrocytic activation, hence, provide further evidences supporting the hypothesis that serotonin may also modulate glial morphology.
authors.affiliation: Departamento de Fisiología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico. limei@servidor.unam.mx
authors.forename: Limei
authors.initials: L
authors.lastname: Zhang
authors.forename: Aleph A
authors.initials: AA
authors.lastname: Corona-Morales
authors.forename: Arturo
authors.initials: A
authors.lastname: Vega-González
authors.forename: Joaquín
authors.initials: J
authors.lastname: García-Estrada
authors.forename: Alfonso
authors.initials: A
authors.lastname: Escobar
mesh_terms: D000679:Amygdala / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D000818:Animals; D001253:Astrocytes / Q000378:metabolism / Q000473:pathology*; D015415:Biomarkers / Q000378:metabolism; D001921:Brain / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D048430:Cell Shape / Q000502:physiology; D003599:Cytoskeleton / Q000378:metabolism / Q000473:pathology*; D005526:Food, Formulated / Q000009:adverse effects*; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D005911:Gliosis / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D006624:Hippocampus / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D006984:Hypertrophy / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D008297:Male; D044342:Malnutrition / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D051381:Rats; D017208:Rats, Wistar; D012701:Serotonin / Q000096:biosynthesis / Q000172:deficiency; D014364:Tryptophan / Q000172:deficiency*
chemical_list: D015415:Biomarkers; D005904:Glial Fibrillary Acidic Protein; D012701:Serotonin; D014364:Tryptophan